FDA broadens label for Amgen’s Uplizna as it enters rare disease competitionnews2025-12-12T12:03:56+00:00December 12th, 2025|Endpoints News|
CDC report underscores benefit of Covid-19 vaccines in kidsnews2025-12-11T20:51:34+00:00December 11th, 2025|Endpoints News|
Geron cuts one-third of staff, focusing on turning Rytelo launch aroundnews2025-12-11T20:24:29+00:00December 11th, 2025|Endpoints News|
EU forges deal over major pharma legislative changesnews2025-12-11T20:00:58+00:00December 11th, 2025|Endpoints News|
GSK’s new antibiotic wins gonorrhea approvalnews2025-12-11T19:19:37+00:00December 11th, 2025|Endpoints News|
Top Trump lawyer calls on SCOTUS to reverse ‘skinny’ generic drug label decisionnews2025-12-11T19:05:07+00:00December 11th, 2025|Endpoints News|
Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trialnews2025-12-11T16:17:38+00:00December 11th, 2025|Endpoints News|
House backs Biosecure Act aimed at Chinese companiesnews2025-12-11T09:52:38+00:00December 11th, 2025|Endpoints News|
In a first, FDA approves a gene therapy from a nonprofitnews2025-12-10T16:02:33+00:00December 10th, 2025|Endpoints News|
UK lowers new medicine rebate scheme to 14.5% for 2026news2025-12-10T11:49:17+00:00December 10th, 2025|Endpoints News|
